Biblio Discovery — Demo Discovery Service

52 hasil untuk "M Azim Ansari"

Menampilkan 1–20 · 0,67 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Extensive C->U transition biases in the genomes of a wide range of mammalian RNA viruses; potential associations with transcriptional mutations, damage- or host-mediated editing of viral RNA

    Peter Simmonds; M. Azim Ansari

    PLOS Pathogens, Vol. 17 No. 6 · 2021 · Inggris · PLOS Scopus

    The rapid evolution of RNA viruses has been long considered to result from a combination of high copying error frequencies during RNA replication, short generation times and the consequent extensive fixation of neutral or adaptive changes over short periods. While both the identities and sites of…

    Juga tersedia di: DOAJ

  2. Artikel Jurnal

    Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era

    Cori Campbell; Monique I. Andersson; M. Azim Ansari dkk.

    Frontiers in Medicine, Vol. 8 · 2021 · Inggris · DOAJ Scopus

    Objectives: Tocilizumab (TCZ), an IL-6 receptor antagonist, is used in the treatment of severe COVID-19 caused by infection with SARS-CoV-2. However, unintended consequences of TCZ therapy include reactivation of tuberculosis (TB) or hepatitis B virus (HBV), and worsening of hepatitis C virus…

  3. Artikel Jurnal Teks lengkap

    A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy

    Louise O. Downs; Cori Campbell; Paul Yonga dkk.

    PLOS Global Public Health, Vol. 3 No. 1 · 2023 · Inggris · PLOS Scopus

    The aim of this systematic review and meta-analysis is to evaluate available prevalence and viral sequencing data representing chronic hepatitis B (CHB) infection in Kenya. More than 20% of the global disease burden from CHB is in Africa, however there is minimal high quality seroprevalence data…

    Juga tersedia di: DOAJ, DOAJ

  4. Artikel Jurnal Teks lengkap

    Genetically distinct within-host subpopulations of hepatitis C virus persist after Direct-Acting Antiviral treatment failure

    Lele Zhao; Matthew Hall; Prahalad Giridhar dkk.

    PLOS Pathogens, Vol. 21 No. 4 · 2025 · Inggris · PLOS Scopus

    Analysis of viral genetic data has previously revealed distinct within-host population structures in both untreated and interferon-treated chronic hepatitis C virus (HCV) infections. While multiple subpopulations persisted during the infection, each subpopulation was observed only intermittently…

    Juga tersedia di: DOAJ

  5. Artikel Jurnal

    Technical Validation of a Hepatitis C Virus Whole Genome Sequencing Assay for Detection of Genotype and Antiviral Resistance in the Clinical Pathway

    Carmen F. Manso; David F. Bibby; Kieren Lythgow dkk.

    Frontiers in Microbiology, Vol. 11 · 2020 · Inggris · DOAJ Scopus

    Choice of direct acting antiviral (DAA) therapy for Hepatitis C Virus (HCV) in the United Kingdom and similar settings usually requires knowledge of the genotype and, in some cases, antiviral resistance (AVR) profile of the infecting virus. To determine these, most laboratories currently use Sanger…

  6. Artikel Jurnal Teks lengkap

    Correction: Hepatitis C virus cascade of care among adults in Sindh province, Pakistan: Findings from 2019–2020 household sero-survey

    Tesfa Sewunet Alamneh; Josephine G. Walker; Aaron G. Lim dkk.

    PLOS Global Public Health, Vol. 6 No. 4 · 2026 · Inggris · PLOS Scopus

    [This corrects the article DOI: 10.1371/journal.pgph.0004706.].

    Juga tersedia di: DOAJ

  7. Artikel Jurnal Teks lengkap

    Hepatitis C virus cascade of care among adults in Sindh province, Pakistan: Findings from 2019–2020 household sero-survey

    Tesfa Sewunet Alamneh; Josephine G. Walker; Aaron G. Lim dkk.

    PLOS Global Public Health, Vol. 5 No. 7 · 2025 · Inggris · PLOS Scopus

    Pakistan has the largest national burden of hepatitis C virus (HCV) infections (9.8 million). High levels of testing and treatment are needed to achieve HCV elimination, but little data exists on this in Pakistan. A household sero-survey from Sindh province (2019–2020) collected self-reported data…

    Juga tersedia di: DOAJ, DOAJ

  8. Artikel Jurnal

    ve-SEQ: Robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens [version 1; referees: 2 approved]

    David Bonsall; M. Azim Ansari; Camilla Ip dkk.

    F1000Research, Vol. 4 · 2015 · Inggris · DOAJ Scopus

    The routine availability of high-depth virus sequence data would allow the sensitive detection of resistance-associated variants that can jeopardize HIV or hepatitis C virus (HCV) treatment. We introduce ve-SEQ, a high-throughput method for sequence-specific enrichment and characterization of…

  9. Artikel Jurnal

    Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection [version 1; peer review: 2 approved]

    Louise O. Downs; Anna L. McNaughton; Mariateresa de Cesare dkk.

    Wellcome Open Research, Vol. 5 · 2020 · Inggris · DOAJ Scopus

    Deep sequencing of the full-length hepatitis B virus (HBV) genome provides the opportunity to determine the extent to which viral diversity, genotype, polymorphisms, insertions and deletions may influence presentation and outcomes of disease. Increasing experience with analysis of HBV genomic data…

  10. Artikel Jurnal

    Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection [version 2; peer review: 2 approved]

    Louise O. Downs; Anna L. McNaughton; Mariateresa de Cesare dkk.

    Wellcome Open Research, Vol. 5 · 2021 · Inggris · DOAJ Scopus

    Deep sequencing of the full-length hepatitis B virus (HBV) genome provides the opportunity to determine the extent to which viral diversity, genotype, polymorphisms, insertions and deletions may influence presentation and outcomes of disease. Increasing experience with analysis of HBV genomic data…

  11. Artikel Jurnal Teks lengkap

    The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV

    Senthil K. Chinnakannan; Tamsin N. Cargill; Timothy A. Donnison dkk.

    Vaccines, Vol. 8 No. 2 · 2020 · Inggris · DOAJ Scopus

    Chronic hepatitis B virus (HBV) infection affects 257 million people globally. Current therapies suppress HBV but viral rebound occurs on cessation of therapy; novel therapeutic strategies are urgently required. To develop a therapeutic HBV vaccine that can induce high magnitude T cells to all…

  12. Artikel Jurnal

    Prevalence of resistance-associated viral variants to the HIV-specific broadly neutralising antibody 10-1074 in a UK bNAb-naïve population

    Panagiota Zacharopoulou; Ming Lee; Thiago Oliveira dkk.

    Frontiers in Immunology, Vol. 15 · 2024 · Inggris · DOAJ Scopus

    Broadly neutralising antibodies (bNAbs) targeting HIV show promise for both prevention of infection and treatment. Among these, 10-1074 has shown potential in neutralising a wide range of HIV strains. However, resistant viruses may limit the clinical efficacy of 10-1074. The prevalence of both de…

  13. Artikel Jurnal

    HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model

    Anna L. McNaughton; José Lourenço; Louise Hattingh dkk.

    BMC Medicine, Vol. 17 No. 1 · 2019 · Inggris · DOAJ Scopus

    Abstract Background Sustainable Development Goals set a challenge for the elimination of hepatitis B virus (HBV) infection as a public health concern by the year 2030. Deployment of a robust prophylactic vaccine and enhanced interventions for prevention of mother to child transmission (PMTCT) are…